New Zealand markets close in 2 hours 53 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
246.08-5.19 (-2.07%)
At close: 04:04PM EDT
246.00 -0.08 (-0.03%)
After hours: 07:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 18.61B
Enterprise value 18.22B
Trailing P/E 28.01
Forward P/E 25.91
PEG ratio (5-yr expected) 3.33
Price/sales (ttm)6.55
Price/book (mrq)7.67
Enterprise value/revenue 6.22
Enterprise value/EBITDA 20.02

Trading information

Stock price history

Beta (5Y monthly) 1.18
52-week change 3-39.95%
S&P500 52-week change 3-16.62%
52-week high 3475.00
52-week low 3244.71
50-day moving average 3304.18
200-day moving average 3347.09

Share statistics

Avg vol (3-month) 3395.89k
Avg vol (10-day) 3467.31k
Shares outstanding 574.05M
Implied shares outstanding 6N/A
Float 873.63M
% held by insiders 10.62%
% held by institutions 196.25%
Shares short (14 Sept 2022) 4834.7k
Short ratio (14 Sept 2022) 42.41
Short % of float (14 Sept 2022) 41.47%
Short % of shares outstanding (14 Sept 2022) 41.13%
Shares short (prior month 14 Aug 2022) 4860.5k

Dividends & splits

Forward annual dividend rate 40.72
Forward annual dividend yield 40.29%
Trailing annual dividend rate 30.71
Trailing annual dividend yield 30.28%
5-year average dividend yield 40.36
Payout ratio 47.92%
Dividend date 302 Aug 2022
Ex-dividend date 418 Jul 2022
Last split factor 22:1
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 23.41%
Operating margin (ttm)26.94%

Management effectiveness

Return on assets (ttm)15.67%
Return on equity (ttm)30.76%

Income statement

Revenue (ttm)2.93B
Revenue per share (ttm)39.26
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)1.18B
EBITDA 913M
Net income avi to common (ttm)685.6M
Diluted EPS (ttm)8.97
Quarterly earnings growth (yoy)0.60%

Balance sheet

Total cash (mrq)718.5M
Total cash per share (mrq)9.7
Total debt (mrq)332.5M
Total debt/equity (mrq)13.72
Current ratio (mrq)3.13
Book value per share (mrq)32.76

Cash flow statement

Operating cash flow (ttm)675.2M
Levered free cash flow (ttm)268.31M